Evidence map›Paper›PMID 36269086›Full record

ArticleJournal of neuropathology and experimental neurology2022

Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.

David G Coughlin, Annie Hiniker, Claire Peterson, Yongya Kim, Sanaz Arezoumandan, Lucia Giannini, Donald Pizzo, Daniel Weintraub, Andrew Siderowf, Irene Litvan and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Digital neuropathology of neurodegenerative disorders: Foundations, research advances, and future directions.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Brain communications · 2024
    Article
  11. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

David G CoughlinFrom the Department of Neurosciences, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-4111-0102
Annie HinikerDepartment of Pathology, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-0055-6610
Claire PetersonDigital Neuropathology Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-6232-919X
Yongya KimFrom the Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
Sanaz ArezoumandanDigital Neuropathology Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-6569-9009
Lucia GianniniDigital Neuropathology Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-3521-3693
Donald PizzoCenter for Advanced Laboratory Medicine, University of California San Diego, La Jolla, California, USA.
Daniel WeintraubDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Andrew SiderowfDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Irene LitvanFrom the Department of Neurosciences, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-3485-3445
Robert A RissmanFrom the Department of Neurosciences, University of California San Diego, La Jolla, California, USA.ORCID 0000-0001-9245-8278
Douglas GalaskoFrom the Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
Lawrence HansenDepartment of Pathology, University of California San Diego, La Jolla, California, USA.
John Q TrojanowskiDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Edward LeeDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-4589-1180
Murray GrossmanDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
David IrwinDigital Neuropathology Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-5599-5098
University of California San Diego · USUniversity of Pennsylvania · USErasmus MC · NL

Funding

UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DETRE, JOHN A · 1991 to 2020
$35.1M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Mark W Bondi · 2019 to 2026
$34.9M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI, ARTHUR W TOGA · 2020 to 2026
$27.8M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Project IV: "Alpha-Synuclein Strains & Diverse Synucleinopathies"P50NS053488 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2007 to 2017
$20.9M
Understanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Corey T McMillan · 2020 to 2026
$18.8M
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"U19AG062418 · NIA · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2019 to 2023
$18.1M
NRSA Training CoreTL1TR001880 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$10.0M
Spreading Tau Pathology in Non-Amnestic Alzheimer's DiseaseR01AG054519 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jeffrey S Phillips · 2018 to 2026
$7.4M
Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson DiseaseK08NS090633 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HINIKER, ANNIE E · 2014 to 2018
$1.1M
Identification of Endophenotypes in the Behavioral-Variant of Frontotemporal DemeK23NS088341 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI IRWIN, DAVID JOHN · 2014 to 2018
$836k
Pathological and cognitive correlations of real time quaking induced conversion in LBD and ADK23NS120038 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI COUGHLIN, DAVID G · 2021 to 2025
$828k
NCATS NIH HHS TL1 TR001880NIA NIH HHS F30 AG063440NIA NIH HHS K01 AG043503NIA NIH HHS P01 AG066597NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066530NIA NIH HHS P30 AG072979NIA NIH HHS P30AG072979NIA NIH HHS R01 AG054519NIA NIH HHS U19 AG062418NINDS NIH HHS K08 NS090633NINDS NIH HHS K23 NS088341NINDS NIH HHS K23 NS120038NINDS NIH HHS L30 NS123995NINDS NIH HHS NS088341NINDS NIH HHS P50 NS053488
6 · The paper itself

Abstract

3R/4R-tau species are found in Alzheimer disease (AD) and ∼50% of Lewy body dementias at autopsy (LBD+tau); 4R-tau accumulations are found in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Digital image analysis techniques can elucidate patterns of tau pathology more precisely than traditional methods but repeatability across centers is unclear. We calculated regional percentage areas occupied by tau pathological inclusions from the middle frontal cortex (MFC), superior temporal cortex (STC), and angular gyrus (ANG) from cases from the University of Pennsylvania and the University of California San Diego with AD, LBD+tau, PSP, or CBD (n = 150) using QuPath. In both cohorts, AD and LBD+tau had the highest grey and white matter tau burden in the STC (p ≤ 0.04). White matter tau burden was relatively higher in 4R-tauopathies than 3R/4R-tauopathies (p < 0.003). Grey and white matter tau were correlated in all diseases (R2=0.43-0.79, p < 0.04) with the greatest increase of white matter per unit grey matter tau observed in PSP (p < 0.02 both cohorts). Grey matter tau negatively correlated with MMSE in AD and LBD+tau (r = -4.4 to -5.4, p ≤ 0.02). These data demonstrate the feasibility of cross-institutional digital histology studies that generate finely grained measurements of pathology which can be used to support biomarker development and models of disease progression.

Indexed as

Alzheimer DiseaseLewy Body DiseaseNeocortexSupranuclear Palsy, ProgressiveTauopathiesWhite MatterHumanstau Proteinstau ProteinsAlzheimer diseaseCorticobasal degenerationDementia with Lewy bodiesDigital histologyNeuropathologyProgressive supranuclear palsyTau

Identifiers

PMID36269086
PMCPMC9677241
OpenAlexW4307032433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.